Home/Filings/4/0001209191-19-024361
4//SEC Filing

Ettenberg Seth 4

Accession 0001209191-19-024361

CIK 0001622229other

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 4:30 PM ET

Size

5.6 KB

Accession

0001209191-19-024361

Insider Transaction Report

Form 4
Period: 2019-03-01
Ettenberg Seth
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-03-01+69,70069,700 total
    Exercise: $4.36Exp: 2029-03-01Common Stock (69,700 underlying)
Footnotes (1)
  • [F1]25% of the shares vests on March 1, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Persons continuous service with the Issuer.

Issuer

Unum Therapeutics Inc.

CIK 0001622229

Entity typeother

Related Parties

1
  • filerCIK 0001734419

Filing Metadata

Form type
4
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:30 PM ET
Size
5.6 KB